(2) Brokaw et al. 54 reported that women with high IGF-I mRNA and IGF-1 peptide levels were at a greater risk for disease progression compared to those with low levels, suggesting that IGF-I is involved in ovarian cancer progression. The gene discussed is IGF1; the disease is ovarian cancer.